How can Nanotech Help?

Strategic Implications Findings

Lorem Elementary Science FairSchool Gymnasium Saturday, May 6th 9am

Lorem ipsum dolor sit amet, ligula suspendisse nulla pretium, rhoncus

tempor placerat fermentum, enim integer ad vestibulum volutpat. Nisl

rhoncus turpis est, vel elit, congue wisi enim nunc ultricies sit, magna

tincidunt. Maecenas aliquam maecenas ligula nostra, accumsan taciti.

Sociis mauris in integer, a dolor netus non dui aliquet, sagittis.

Eget habitasse elementum est, ipsum(123) 456 - 7890

What is the Future of n a n o t e c h n o l o g y in the Diagnosis & Treatment of Heart Disease?

Nanotech Trends

Current TreatmentTroubling Trends

Nano Particles Increase Stent Success

Can heal scar tissue and reduce blood clots

ABSTRACT-Increasing incidence of heart disease: 5

million more cases by 2020

-Stalling success rate for heart stents

-Nanotechnology can save the American

economy $57.52 billion per year after 2020

-Number of patents vs. 6 key indicators

•Long-term business opportunities

Artificial Arteries

1) Mimic human artery movements, & replace heart stents in the future. 2) Designed to last the life of the patient3) Eliminate the need for repeat surgeries4) Can regenerate surrounding tissue5) Undergoing FDA Clinical trials

NANOTECHNOLOGY VALUE CHAIN

FUTURE

SCENARIOS

“Those stagnant numbers highlight the need for continued development of new technologies and devices for opening blocked heart arteries” (Bhatt).

Dr. Deepak Bhatt, the Associate Director of the Cleveland Clinic

Cardiovascular Coordinating Center,

THE LOW DOWN

• Businesses: 1) Vital to continue investment in nanotech 2) Partnerships with IT sector to increase efficiency of investments

• Growth: Pharmaceutical, Diagnostic, Medical Devices for Nanotech projected to increase to over $120 Billion by 2020

• Importance: Vast majority of companies polled consider nanotech a key strategy and possibility for new markets

• Productivity: 1) High demand for specialized, skilled workers 2) Drastically improve health of work force, offering work until older

• Challenges: 1) high cost of capital, 2) long FDA approval processes, 3) high cost of products, 4)patent protection 5)Ethics